Professor David Price
Chair of Primary Care Respiratory Med
- About
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 9 of 93 Results 81 to 90 of 923
Baseline disease burden in severe asthma patients treated with biologics, and eligible but not treated: Spanish patients in the ISAR Registry
EAACI Congress 2024Contributions to Conferences: AbstractsClinical Characteristics of Patients with Severe Asthma by Different Elevated Biomarkers Classifications: patients from Spain in the ISAR Registry
EAACI Congress 2024Contributions to Conferences: AbstractsBudesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication Success
International journal of chronic obstructive pulmonary disease , vol. 19, pp. 1153-1166Contributions to Journals: ArticlesBisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial
JAMA, vol. 332, no. 6, pp. 462-470Contributions to Journals: ArticlesPre-asthma: a useful concept? A EUFOREA paper. Part 2—late onset eosinophilic asthma
Frontiers in Allergy, vol. 5, 1404735Contributions to Journals: Review articles- [ONLINE] DOI: https://doi.org/10.3389/falgy.2024.1404735
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/be6aebd0-502e-464c-8fb8-15ac7033ea9b/download
- [ONLINE] View publication in Scopus
The clinical burden associated with unregulated access to short-acting β2-agonists in patients with asthma: Findings from the SABINA III study
12th IPCRG World ConferenceContributions to Conferences: Abstracts- [ONLINE] https://www.ipcrg.org/24113
Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care
Thorax, vol. 79, no. 5, pp. 403-411Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/thorax-2023-220512
- [ONLINE] View publication in Scopus
Longitudinal patterns of intermittent oral corticosteroid use for asthma in the UK
Journal of Allergy and Clinical Immunology: Global, vol. 3, no. 2, 100225Contributions to Journals: ArticlesDevelopment and validation of an individualised risk prediction model for exacerbations in patients with severe asthma in real-world settings
ATS 2024, A6700Contributions to Journals: AbstractsImpact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma
Annals of Allergy, Asthma, and Immunology, vol. 132, no. 5, pp. 610-622Contributions to Journals: Articles